홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 바이오테크놀러지 > 맞춤형의료 > Strategic Analysis of the European Markets for Theranostics
카테고리
바이오테크놀러지 (1590)
게놈 창약 (202)
맞춤형의료 (51)
바이오마커 (154)
바이오매트리얼 (54)
바이오장비 (357)
분자표적치료(MTT) (131)
유전자 치료/RNAi (101)
재생의학 (124)
항체/면역 (191)
시장보고서

Strategic Analysis of the European Markets for Theranostics

리서치사 Frost & Sullivan
발행일 2009년 05월 상품코드 89718
페이지 정보 53 Pages
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.

Table of Contents

1. STRATEGIC ANALYSIS OF THE EUROPEAN MARKETS FOR THERANOSTICS

Overview

  • Overview

Research Scope and Methodology

  • Research Scope and Methodology

Background and Applications of Theranostics

  • Benefits of Theranostics
  • Test Categories
  • Stakeholder Analysis
  • Pharma-diagnostic Convergence
  • Opportunities
  • Role in Pharmaceutical Industry
  • Application in Drug Development Process

Key Industry Challenges and Recommendations

  • Industry Challenges

Key Market Dynamics: Drivers and Restraints

  • Drivers and Restraints

Key Disease Areas:Role of Theranostics

  • Disease Areas

Special Focus:Oncology

  • Oncology
  • Recent Advances in Cancer Theranostics

Competitive Overview

  • Competitive Overview
  • Drugs with Companion Tests

Regulatory Scenario : FDA and EMEA Perspective

  • Regulatory Scenario

SWOT Analysis

  • SWOT Analysis

Conclusion

  • Conclusion

Decision Support Database

  • Decision Support Database

Key Industry Participants

  • Key Industry Participants
Back to Top